The nanomechanical responses of two crystalline phases of adihydropyrimidine analogue(1)were similar irrespective of the presence (or absence) of the guest solvent. In contrast, the mechanical responses of two differently solvated forms of the second related( 2)c rystals were significantly different.T hese contrasting behaviors are rationalized in terms of intermolecular interactions and energy distributions.Al arge number of molecules crystallize with guest solvent molecules. In particular, nearly one-third of pharmaceuticals prefer to form guest inclusion compounds. [1] Such solvatomorphso fagiven compound can exhibit different physicochemicalp roperties such as solubility,t hermal stability,a nd mechanical strength. [2,3] So, it is of importance to understand the role of solvent molecules in determining the mechanical properties of the solvatomorphs,e specially in view of the recent understanding of the structure-property correlations in organic molecular crystals. [4,5] This is because mechanical properties such as hardness( H)c an play an important role in the manufacturing of pharmaceutical tablets. [6] Severals tudies to interrelate nanomechanical responses (H and elastic modulus, E)w ith the intermolecular interactions presenti nt he crystal structureh ave been performed for differentp olymorphs and co-crystals employing the technique of nanoindentation. [7][8][9] So far,r elativelyf ew molecular-level studies have been performed involving nanomechanical diversity in solvatomorphs. [4, 10] In this communication,w eattempt to address the role of solvents in alteredn anomechanical responses in organic crystals, in particular with respect to the supramolecular structure and energetic stabilization via the presence of relevant intermolecular interactions. We present here the observation of anisotropic response in mechanical properties in solvatomorphs of two compounds (Scheme 1), namely,m ethyl 6-methyl-2-oxo-4-(4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate (1)a nd (1-(4-(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)methyl 4-(4-chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (2). The subject compounds 1, and 2, contains the chemical moiety hydropyrimidine, which displays aw ide range of pharmacological activities. [11] The crystal structure-mechanical property relationships, whicha re dependento nt he presence of the specific solventp resent in the four crystal structures (two each for compound 1 and 2), are discussed via an analysis of the nature and energetics of the intermolecular interaction topologies alongw ith their relative orientations with respect to the specific direction of the mechanical stress.The crystallization screening for both synthesized compounds (1 and 2)i nv ariouss olvents followed by single crystal X-ray diffractiond ata (SCXRD) collection revealed that 1 crystallizesi no ne solvent-free (1-FI)a nd another phase whichi ncludesd ichloromethane (DCM) (1-FII). On the other hand, 2 exists in two crystal phases, with acetonitrile (ACN) (2-F...